Thiocolchicoside a semi-synthetic derivative of the Glory Lily: a new weapon to fight metastatic bone resorption?: Thiocolchicoside to treat metastatic bone

Abstract : Metastatic bone disease is a serious clinical complication for the treatment of patients with advanced cancer, but few therapeutic options are currently available. Bisphosphonates are an established standard care for these patients, but new treatments are now emerging, including the use of monoclonal antibodies targeting the RANK ligand. In this issue of the BJP, Reuter et al. provide evidence that thiocolchicoside, a semi-synthetic derivative of the naturally occurring colchicoside, extracted from the seeds of Gloriosa superba (Liliaceae), prevented osteoclactogenesis by suppressing RANK ligand-mediated NF-κB activation. Thiolcolchicoside may thus represent an attractive therapeutic option for the management of bone metastatic disease.
Type de document :
Article dans une revue
British Journal of Pharmacology, Wiley, 2012, 165 (7), pp.2124-6. 〈10.1111/j.1476-5381.2011.01792.x〉
Liste complète des métadonnées

Littérature citée [8 références]  Voir  Masquer  Télécharger

http://www.hal.inserm.fr/inserm-00823463
Contributeur : Olivier Micheau <>
Soumis le : vendredi 17 mai 2013 - 09:17:24
Dernière modification le : dimanche 11 février 2018 - 01:14:56
Document(s) archivé(s) le : mardi 4 avril 2017 - 07:46:49

Fichiers

Brit_J_Pharmacol_Micheau_final...
Fichiers produits par l'(les) auteur(s)

Identifiants

Collections

Citation

Olivier Micheau, Florent Dufour, Henning Walczak. Thiocolchicoside a semi-synthetic derivative of the Glory Lily: a new weapon to fight metastatic bone resorption?: Thiocolchicoside to treat metastatic bone. British Journal of Pharmacology, Wiley, 2012, 165 (7), pp.2124-6. 〈10.1111/j.1476-5381.2011.01792.x〉. 〈inserm-00823463〉

Partager

Métriques

Consultations de la notice

209

Téléchargements de fichiers

473